Skip to main content
SpringerLink
Log in

Neues zur Thoraxpathologie

Bericht der AG 2019

Thoracic pathology news

Report of the DGP working group 2019

  • Berichte der Arbeitsgemeinschaften
  • Published:
Der Pathologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Büttner R, Wolf J, Kron A, Nationales Netzwerk Genomische Medizin (nNGM) (2019) Modell für eine innovative Diagnostik und Therapie von Lungenkrebs im Spannungsfeld eines öffentlichen Versorgungsauftrages. Pathologe 40(3):276–280. https://doi.org/10.1007/s00292-019-0605-4 (Review. German. PubMed PMID: 31101971)

    Article  PubMed  Google Scholar 

  2. Rindi G, Klimstra DS, Abedi-Ardekani B et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31(12):1770–1786. https://doi.org/10.1038/s41379-018-0110-y

    Article  PubMed  PubMed Central  Google Scholar 

  3. Alcala N, Leblay N, Gabriel AAG et al (2019) Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun 10(1):3407. https://doi.org/10.1038/s41467-019-11276-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Derks JL, Leblay N, Lantuejoul S et al (2018) New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management. J Thorac Oncol 13(6):752–766. https://doi.org/10.1016/j.jtho.2018.02.002 (Erratum in: J Thorac Oncol. 2018 Aug;13(8):1229. PubMed PMID: 29454048.)

    Article  PubMed  Google Scholar 

  5. George J, Lim JS, Jang SJ et al (2015) Comprehensive genomic profiles of small cell lung cancer. Nature 524(7563):47–53. https://doi.org/10.1038/nature14664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fernandez-Cuesta L, Peifer M, Lu X et al (2014) Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat Commun 5:3518. https://doi.org/10.1038/ncomms4518

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Peifer M, Fernández-Cuesta L, Sos ML et al (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44(10):1104–1110. https://doi.org/10.1038/ng.2396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Duruisseaux M, Martínez-Cardús A, Calleja-Cervantes ME et al (2018) Epigenetic prediction of response to anti-PD‑1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis. Lancet Respir Med 6(10):771–781. https://doi.org/10.1016/S2213-2600(18)30284-4

    Article  CAS  PubMed  Google Scholar 

  9. Duruisseaux M, Esteller M (2018) Lung cancer epigenetics: from knowledge to applications. Semin Cancer Biol 51:116–128. https://doi.org/10.1016/j.semcancer.2017.09.005

    Article  CAS  PubMed  Google Scholar 

  10. Petersen I (2018) Predictive pathology of lung cancer immunotherapy response. Lancet Respir Med 6(10):731–733. https://doi.org/10.1016/S2213-2600(18)30333-3

    Article  PubMed  Google Scholar 

  11. Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555(7697):469–474. https://doi.org/10.1038/nature26000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Koelsche C, Hartmann W, Schrimpf D et al (2018) Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information. Mod Pathol 31(8):1246–1256. https://doi.org/10.1038/s41379-018-0045-3

    Article  CAS  PubMed  Google Scholar 

  13. Petersen I (2018) Entitäten der Weichteilsarkome – Den Gegner kennen. Trauma Berufskrankh 20:25–32. https://doi.org/10.1007/s10039-017-0339-6

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Pathologie und Zytodiagnostik Gera, SRH Poliklinik Gera GmbH, Straße des Friedens 122, 07548, Gera, Deutschland

    I. Petersen

Authors
  1. I. Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Petersen.

Ethics declarations

Interessenkonflikt

I. Petersen gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

The supplement containing this article is not sponsored by industry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Petersen, I. Neues zur Thoraxpathologie. Pathologe 40 (Suppl 3), 396–398 (2019). https://doi.org/10.1007/s00292-019-00681-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-019-00681-y

Search

Navigation